Home > Insider Trading > Filing (0001209191-17-053010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1581950	Jr. Clayton Lewis Cantley	C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-09-13	1,000	$65.47	86,394	No	4	S	Direct
Common Stock	Disposition	2017-09-13	1,000	$65.47	86,434	No	4	S	Indirect	See footnote
Common Stock	Disposition	2017-09-14	1,000	$65.71	85,394	No	4	S	Direct
Common Stock	Disposition	2017-09-14	1,000	$65.71	85,434	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Direct
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,803	Indirect	See footnote
Common Stock	20,803	Indirect	See footnote

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $65.15 to $65.92. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Shares held by Vicki Lee Sato, who is the reporting person's spouse.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $65.45 to $66.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.